1型糖尿病中脑损伤血浆生物标志物及其与脑MRI和认知的关联
在DCCT/EDIC研究的373例1型糖尿病成人中,评估血浆脑损伤生物标志物与MRI及认知指标的关联。较高的神经丝轻链(NfL)与预测脑龄增加及认知损害风险升高相关,NfL和pTau-181与精神运动及心理效率较低相关,而淀粉样蛋白β指标与研究所测指标无关联。平均HbA1c每升高1%与NfL和pTau-181升高相关。
要点
- NfL每升高20%,预测脑龄增加0.51年,认知损害风险升高19.5%。
- NfL和pTau-181较高与精神运动及心理效率较低相关,与记忆无关。
- 平均HbA1c每升高1%,NfL升高14.6%,pTau-181升高12.8%。
核心结论
- 在该老龄1型糖尿病队列中,脑损伤生物标志物未呈现阿尔茨海默病样特征;NfL因与较高HbA1c、MRI上脑老化加速及认知功能障碍相关而成为值得关注的生物标志物;研究提示1型糖尿病成人的早期神经退行性变可能由非阿尔茨海默病/非淀粉样蛋白机制所致。
研究设计与样本
- 研究纳入373名参与DCCT/EDIC研究的1型糖尿病成人,检测血浆淀粉样蛋白β-40、淀粉样蛋白β-42、神经丝轻链(NfL)、磷酸化Tau-181(pTau-181)和胶质纤维酸性蛋白(GFAP)。
主要发现
- 参与者年龄60岁(范围44-74),1型糖尿病病程38年(范围30-51)。
- NfL较高与预测脑龄增加相关(NfL每升高20%,预测脑龄增加0.51年;P < 0.001),并与认知损害风险升高19.5%相关(P < 0.01)。
- NfL和pTau-181较高与精神运动及心理效率较低相关(P < 0.001),但与记忆较差无关。
- 淀粉样蛋白β指标与研究所测指标无关联。
- 平均HbA1c每升高1%,NfL升高14.6%,pTau-181升高12.8%(P < 0.0001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate associations between plasma biomarkers of brain injury and MRI and cognitive measures in participants with type 1 diabetes (T1D) from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. RESEARCH DESIGN AND METHODS: Plasma amyloid-β-40, amyloid-β-42, neurofilament light chain (NfL), phosphorylated Tau-181 (pTau-181), and glial fibrillary acidic protein (GFAP) were measured in 373 adults who participated in the DCCT/EDIC study. MRI assessments included total brain and white matter hyperintensity volumes, white matter mean fractional anisotropy, and indices of Alzheimer disease (AD)-like atrophy and predicted brain age. Cognitive measures included memory and psychomotor and mental efficiency tests and assessments of cognitive impairment. RESULTS: Participants were 60 (range 44-74) years old with 38 (30-51) years' T1D duration. Higher NfL was associated with an increase in predicted brain age (0.51 years per 20% increase in NfL; P < 0.001) and a 19.5% increase in the odds of impaired cognition (P < 0.01). Higher NfL and pTau-181 were associated with lower psychomotor and mental efficiency (P < 0.001) but not poorer memory. Amyloid-β measures were not associated with study measures. A 1% increase in mean HbA1c was associated with a 14.6% higher NfL and 12.8% higher pTau-181 (P < 0.0001). CONCLUSIONS: In this aging T1D cohort, biomarkers of brain injury did not demonstrate an AD-like profile. NfL emerged as a biomarker of interest in T1D because of its association with higher HbA1c, accelerated brain aging on MRI, and cognitive dysfunction. Our study suggests that early neurodegeneration in adults with T1D is likely due to non-AD/nonamyloid mechanisms.
引用
- Karger AB, Nasrallah IM, Braffett BH, et al. Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes. Diabetes Care. 2024. PMID: 38861647. doi:10.2337/dc24-0229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。